RecruitingNCT04995640

CILCA Arch Registry: Management and Outcomes of Open and Endovascular Repair

CILCA Registry: Aortic Arch Variant With a Common Origin of the Innominate and Left Carotid Artery. Management and Outcomes of Open and Endovascular Repair.


Sponsor

Ospedale San Donato

Enrollment

500 participants

Start Date

Oct 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

This registry aims to provide insights on the pathogenic mechanisms that expose subjects with CILCA arch to the increased risk of postoperative complications. So, the CILCA arch registry will capture clinical data and medical images of subjects with CILCA arch treated by surgical or endovascular (TEVAR) means. Study Design: International Multicenter and Observational registry Estimated Enrolment: 500 patients, with competitive enrolment. Clinical Follow up: Postoperatively at 30 days, at 12 months, and yearly after.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Age ≥ 18 years old
  • CILCA arch treated for an aortic disease (i.e. aortic dissection, aneurysm)

Exclusion Criteria2

  • Contraindications to computed tomography (e.g. hypersensitivity to contrast media, renal failure);
  • Suspected or manifested pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREopen cardiovascular repair or endovascular treatment (TEVAR)

Surgery type: open cardiovascular repair and endovascular treatment (TEVAR)


Locations(1)

IRCCS Policlinico San Donato

San Donato Milanese, Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04995640


Related Trials